Total Payments
$8,023
2024 Payments
$1,274
Companies
39
Transactions
491
Medicare Patients
1,021
Medicare Billing
$118,362
Payment Breakdown by Category
Food & Beverage$7,954 (99.2%)
Education$68.08 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,954 | 488 | 99.2% |
| Education | $68.08 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,556 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $700.15 | 28 | $0 (2024) |
| Corium, LLC | $643.58 | 38 | $0 (2024) |
| Novo Nordisk Inc | $493.00 | 35 | $0 (2022) |
| IRONSHORE PHARMACEUTICALS INC. | $444.25 | 25 | $0 (2024) |
| Lilly USA, LLC | $388.79 | 27 | $0 (2024) |
| PFIZER INC. | $326.13 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $314.26 | 18 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $304.04 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $274.98 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,274 | 69 | ABBVIE INC. ($314.32) |
| 2023 | $1,665 | 88 | AbbVie Inc. ($521.93) |
| 2022 | $1,306 | 82 | ABBVIE INC. ($357.38) |
| 2021 | $981.96 | 61 | AbbVie Inc. ($362.56) |
| 2020 | $572.41 | 39 | Allergan, Inc. ($183.35) |
| 2019 | $751.38 | 46 | AstraZeneca Pharmaceuticals LP ($175.49) |
| 2018 | $711.81 | 46 | Novo Nordisk Inc ($136.20) |
| 2017 | $760.52 | 60 | Novo Nordisk Inc ($161.44) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: VACCINE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: ADHD | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: ADHD | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 09/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: VACCINE | ||||||
| 08/28/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), VAXELIS | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Vaccines | ||||||
| 08/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: VACCINES | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 08/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 214 | 376 | $81,361 | $29,656 |
| 2022 | 6 | 208 | 312 | $64,503 | $22,446 |
| 2021 | 10 | 294 | 493 | $97,583 | $37,287 |
| 2020 | 9 | 305 | 491 | $89,910 | $28,974 |
Total Patients
1,021
Total Services
1,672
Medicare Billing
$118,362
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 190 | $44,650 | $15,086 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 77 | $25,256 | $9,566 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 48 | $8,400 | $2,550 | 30.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $1,725 | $1,651 | 95.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $910.00 | $751.40 | 82.6% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 12 | 12 | $420.00 | $51.48 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 160 | $37,600 | $12,316 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 51 | $16,728 | $5,817 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 42 | $7,350 | $2,294 | 31.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 19 | $1,425 | $1,302 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $840.00 | $647.76 | 77.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 16 | 16 | $560.00 | $69.28 | 12.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 158 | $37,130 | $12,705 | 34.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 66 | $21,648 | $8,772 | 40.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 81 | $11,340 | $4,357 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 52 | $8,340 | $3,069 | 36.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 33 | $6,600 | $2,645 | 40.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,175 | $1,893 | 87.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $4,500 | $1,586 | 35.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 13 | $2,860 | $1,064 | 37.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 12 | $1,800 | $666.00 | 37.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 34 | 34 | $1,190 | $531.42 | 44.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 188 | $42,872 | $12,548 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 88 | $12,320 | $4,970 | 40.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 30 | 48 | $15,164 | $4,375 | 28.9% |
About Dr. William Tomlinson, MD
Dr. William Tomlinson, MD is a Internal Medicine healthcare provider based in Parkersburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578686226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Tomlinson, MD has received a total of $8,023 in payments from pharmaceutical and medical device companies, with $1,274 received in 2024. These payments were reported across 491 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,954).
As a Medicare-enrolled provider, Tomlinson has provided services to 1,021 Medicare beneficiaries, totaling 1,672 services with total Medicare billing of $118,362. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Parkersburg, WV
- Active Since 04/09/2007
- Last Updated 08/18/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1578686226
Products in Payments
- UBRELVY (Drug) $636.96
- VRAYLAR (Drug) $528.32
- Azstarys (Drug) $506.09
- QULIPTA (Drug) $498.16
- FARXIGA (Drug) $422.35
- JORNAY PM (Drug) $400.44
- TRULICITY (Drug) $270.58
- Adzenys XR-ODT (Drug) $268.55
- NURTEC ODT (Drug) $194.43
- Ozempic (Drug) $177.87
- Cologuard Collection Kit (Device) $163.98
- Victoza (Drug) $162.14
- QELBREE (Drug) $154.13
- SOLIQUA 100/33 (Biological) $151.42
- Trintellix (Drug) $151.40
- AIRSUPRA (Drug) $151.39
- JARDIANCE (Drug) $141.80
- BEXSERO (Biological) $139.93
- AZSTARYS (Drug) $137.49
- KEVEYIS (Drug) $112.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parkersburg
Jennifer Leavitt, D.o, D.O
Internal Medicine — Payments: $9,943
Internal Medicine $9,943
Orton Armstrong, M.d, M.D
Internal Medicine — Payments: $9,663
Internal Medicine $9,663
Bairava Kuppuswamy, M.d, M.D
Internal Medicine — Payments: $6,502
Internal Medicine $6,502
Michael Cheshire, D.o, D.O
Internal Medicine — Payments: $5,388
Internal Medicine $5,388
Abiy Kelil, M.d, M.D
Internal Medicine — Payments: $3,922
Internal Medicine $3,922
Brownhilda Santo, Md, MD
Internal Medicine — Payments: $3,793
Internal Medicine $3,793